HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness

NCT07369622 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Gout Initiating Urate-loweringUrate-lowering Therapy
Gout Arthritis
Gout and Hyperuricemia

Interventions

DIAGNOSTIC_TEST: HLA-B*58:01 Genotyping
DRUG: Allopurinol Tablet
DRUG: Febuxostat

Sponsor

Haiphong University of Medicine and Pharmacy